Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL*
暂无分享,去创建一个
[1] R. Kinobe,et al. Peroxynitrite-mediated inactivation of heme oxygenases , 2004, BMC pharmacology.
[2] Peng Yang,et al. Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. , 2003, Life sciences.
[3] G. Ansari,et al. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. , 1992, Toxicology.
[4] D. Petersen,et al. Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal. , 2004, Biochemistry.
[5] M. Richard,et al. Effects of chronic ethanol exposure on acetaldehyde and free radical production by astrocytes in culture. , 2000, Alcohol.
[6] A. Daoud,et al. Sequential morphologic studies of regression of advanced atherosclerosis. , 1981, Archives of pathology & laboratory medicine.
[7] B. Björkerud,et al. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[8] D. Kinden,et al. Atherosclerosis in Rabbits Fed a Low Cholesterol Dietfor Five Years , 1982, Arteriosclerosis.
[9] P G Anderson,et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. , 1994, Biological chemistry Hoppe-Seyler.
[10] G. Opiteck,et al. In Vitro Biomarker Discovery for Atherosclerosis by Proteomics* , 2004, Molecular & Cellular Proteomics.
[11] R. Gerrity,et al. Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980, Artery.
[12] W. Pearce,et al. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation , 1994, Agents and Actions.
[13] N. Sherman,et al. Protein Sequencing and Identification Using Tandem Mass Spectrometry: Kinter/Tandem Mass Spectrometry , 2000 .
[14] B. Schreiber,et al. Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] D. Ross,et al. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Pietraforte,et al. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. , 1998, Archives of biochemistry and biophysics.
[17] Jordi Félez,et al. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase , 2003, American journal of hematology.
[18] Y. Sun,et al. Stable H2O2-resistant variants of Chinese hamster fibroblasts demonstrate increases in catalase activity. , 1988, Radiation research.
[19] D. Steinberg,et al. Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.
[20] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[21] G. Favre,et al. Tamoxifen Is a Potent Inhibitor of Cholesterol Esterification and Prevents the Formation of Foam Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.
[22] S. Horwitz,et al. The Microtubule-destabilizing Activity of Metablastin (p19) Is Controlled by Phosphorylation* , 1997, The Journal of Biological Chemistry.
[23] H. Rus,et al. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. , 1996, Atherosclerosis.
[24] W. Blaner,et al. 9-cis-retinoids: biosynthesis of 9-cis-retinoic acid. , 2000, Biochemistry.
[25] D. Steinberg,et al. Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.
[26] W. Dewey,et al. Hydrogen peroxide or heat shock induces resistance to hydrogen peroxide in Chinese hamster fibroblasts , 1987, Journal of cellular physiology.
[27] M. Malinow,et al. Ultrastructure of experimental coronary artery atherosclerosis in cynomolgus macaques. A comparison with the lesions of other primates. , 1982, Atherosclerosis.
[28] A. Namane,et al. Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .
[29] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[30] A. Mantovani,et al. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. , 2003, Trends in immunology.
[31] R. Morton,et al. Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP)* , 2003, Journal of Biological Chemistry.
[32] E. B. Smith. THE INFLUENCE OF AGE AND ATHEROSCLEROSIS ON THE CHEMISTRY OF AORTIC INTIMA. 1. THE LIPIDS. , 1965, Journal of atherosclerosis research.
[33] M. Brown,et al. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.
[34] G. Chisolm,et al. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.
[35] C. Cross,et al. Inactivation of glutathione S-transferases by nitric oxide-derived oxidants: exploring a role for tyrosine nitration. , 2001, Archives of biochemistry and biophysics.
[36] D. Morel,et al. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.
[37] D. Steinberg,et al. The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.
[38] P. Libby,et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] T. Shimokama,et al. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis , 2005, Virchows Archiv A.
[40] A. Tall,et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.
[41] A. Nel,et al. Nitrotyrosine‐modified proteins and oxidative stress induced by diesel exhaust particles , 2005, Electrophoresis.
[42] H. Fung,et al. Mechanism-based partial inactivation of glutathione S-transferases by nitroglycerin: tyrosine nitration vs sulfhydryl oxidation. , 2003, Nitric oxide : biology and chemistry.
[43] F. Spener,et al. Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. , 1998, European journal of biochemistry.
[44] P. Libby,et al. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.
[45] D. Dewitt,et al. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.
[46] Terry J. Smith,et al. Leukoregulin Induction of Prostaglandin-Endoperoxide H Synthase-2 in Human Orbital Fibroblasts , 1996, The Journal of Biological Chemistry.
[47] D. Dewitt,et al. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. , 1995, Seminars in nephrology.
[48] P. Yu,et al. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. , 1998, Atherosclerosis.
[49] M. Daemen,et al. Identification of Genes Potentially Involved in Rupture of Human Atherosclerotic Plaques , 2001, Circulation research.
[50] Elspeth B. Smith,et al. The influence of age and atherosclerosis on the chemistry of aortic intima , 1965 .
[51] J. Hamilton,et al. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[52] P. Nelson,et al. Dual-substrate Specificity Short Chain Retinol Dehydrogenases from the Vertebrate Retina* 210 , 2002, The Journal of Biological Chemistry.
[53] E. B. Smith,et al. Lipid in the aortic intima. The correlation of morphological and chemical characteristics. , 1967, Journal of atherosclerosis research.
[54] F. Ursini,et al. LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. , 1997, Journal of lipid research.
[55] E. Lubberts,et al. Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. , 2002, The American journal of pathology.
[56] O. Stein,et al. Macrophage cholesterol efflux to free apoprotein A-I in C3H and C57BL/6 mice. , 2002, Biochemical and biophysical research communications.
[57] M. N. Hughes,et al. Interaction of bilirubin and biliverdin with reactive nitrogen species , 2003, FEBS letters.
[58] C. Selzman,et al. Interleukin-10 attenuates the response to vascular injury. , 2004, The Journal of surgical research.
[59] C. Turck,et al. A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] S. Glagov,et al. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. , 1980, The American journal of pathology.
[61] James L. Young,et al. Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages , 2002, The Journal of experimental medicine.
[62] Gerrity Rg,et al. Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980 .
[63] F. Bell,et al. Arterial fatty acid-binding protein activity associated with dietarily-induced and spontaneously occurring atherosclerosis in the rabbit (Oryctolagus cuniculus). , 1990, Comparative biochemistry and physiology. B, Comparative biochemistry.
[64] M. Salmona,et al. Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis , 2005, Journal of Biological Chemistry.
[65] Roland Somogyi,et al. Large Scale Gene Expression Analysis of Cholesterol-loaded Macrophages* , 2000, The Journal of Biological Chemistry.
[66] R. Dean,et al. Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression. , 1997, Atherosclerosis.
[67] William A. Boisvert,et al. Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.
[68] Jeffrey B. Boord,et al. Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice , 2004, Circulation.
[69] C. Argmann,et al. Activation of Peroxisome Proliferator–Activated Receptor Gamma and Retinoid X Receptor Results in Net Depletion of Cellular Cholesteryl Esters in Macrophages Exposed to Oxidized Lipoproteins , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[70] F. Bell,et al. Temporal evaluation of fatty acid-binding protein (FABP) activity in association with the development of atherosclerosis in the rabbit. , 1992, Comparative biochemistry and physiology. Comparative physiology.
[71] Hyung-Sik Kang,et al. IL‐6 induces hepatic inflammation and collagen synthesis in vivo , 1994, Clinical and experimental immunology.
[72] T. Hara,et al. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. , 2000, The American journal of pathology.
[73] S. Park,et al. Identification of a zeta-crystallin (quinone reductase)-like 1 gene (CRYZL1) mapped to human chromosome 21q22.1. , 1999, Genomics.
[74] P. Libby,et al. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. , 1999, The American journal of pathology.
[75] D. Ross,et al. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. , 1996, Environmental health perspectives.
[76] C. Richards,et al. Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice1 , 2003, The Journal of Immunology.